Wolverine Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$741K Hold
54,100
– – 0.01% 934
2026
Q2
$733K Hold
54,100
– – 0.01% 868
2026
Q1
$324K Sell
54,100
-10,000
-16% -$75.2K ﹤0.01% 1017
2025
Q4
$460K Buy
64,100
+49,100
+327% +$388K ﹤0.01% 946
2025
Q3
$160K Hold
15,000
– – ﹤0.01% 1051
2025
Q2
$145K Buy
15,000
+7,400
+97% +$76.3K ﹤0.01% 1067
2025
Q1
$113K Buy
7,600
+1,200
+19% +$18.5K ﹤0.01% 1081
2024
Q4
$95.5K Buy
6,400
+5,600
+700% +$91.3K ﹤0.01% 1119
2024
Q3
$15.3K Hold
800
– – ﹤0.01% 1291
2024
Q2
$16.6K Hold
800
– – ﹤0.01% 1283
2024
Q1
$15K Sell
800
-28,500
-97% -$489K ﹤0.01% 1244
2023
Q4
$423K Buy
29,300
+1,300
+5% +$17.7K ﹤0.01% 919
2023
Q3
$486K Buy
28,000
+23,700
+551% +$494K 0.01% 884
2023
Q2
$89.5K Buy
4,300
+2,600
+153% +$56.5K ﹤0.01% 1096
2023
Q1
$40K Buy
1,700
+1,600
+1,600% +$43K ﹤0.01% 1238
2022
Q4
$2.79K Buy
+100
New +$2.56K ﹤0.01% 1831

Other funds holding OGN

Wolverine Asset Management's OGN Position: Q3 2026 in Review

Wolverine Asset Management reduced its Organon & Co (OGN) stake by 34% in Q3 2026, selling an estimated $962K and leaving 137,360 shares worth $1.88M. The position accounts for 0.01% of the portfolio, ranked #668.

Wolverine Asset Management first reported a position in OGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.82M in Q2 2026. 608 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Wolverine Asset Management held 137,360 shares of Organon & Co worth $1.88M as of Q3 2026.
  • Wolverine Asset Management sold 70,555 Organon & Co shares in Q3 2026, an estimated $962K.
  • Organon & Co made up 0.01% of Wolverine Asset Management's portfolio in Q3 2026, its #668 holding.
  • Wolverine Asset Management first reported a position in Organon & Co in Q4 2023 and has held it in 12 quarters since.
  • Wolverine Asset Management's Organon & Co position peaked at $2.82M in Q2 2026.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.